Streamly
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Categories & TopicsEvents & BrandsExperts
LoginSign Up
Carbon MitigationResiliencyEnergyResourcesBiodiversitySocial Sustainability Tools & FrameworksStrategy
Private CapitalBankingFintechWealth & Investment ManagementInsurance
Content StrategyData & AnalyticsSocial MediaLeadership & CultureMarketing Strategy
Growth StrategyLeadership & CultureTools & MethodologyCybersecurityTelecommunications
Leadership & CultureTools & MethodologyConsumer InsightsStrategy
RenewablesHydrogenBiofuelsEnergy & Battery StorageDecarbonisationInfrastructure & Development
Digital HealthChronic DiseaseAged Care & DisabilityHospital ManagementFunding, Policy & WorkforceLegal & Ethical IssuesBiotech & PharmaHealth Infrastructure
RestaurantsIndustryMenuCulinaryRetailWorkforceOperationsConsumers
Leadership & CultureStrategyDiversity, Equity & InclusionInspiration
Future of WorkLearning & Development Employee ExperienceHR TechLeadership & CultureTalent Acquisition
RailHaulage & Freight DecarbonisationInfrastructure
SustainabilityFinanceMarketingInnovation & TechnologyData & InsightsEnergyHealthcareFoodserviceLeadershipHRTransport & InfrastructureMeetings & EventsBuildings & Real Estate

The key to a successful capital raise & non-dilutive funding

The key to a successful capital raise & non-dilutive funding

0:00
0%
0:00
|
0:00
https://cdn.streamly.video/From_Lab_to_Market_Stories_of_Biotech_2_06efffdad0.png
PREVIEW
BiotechPharma/Biotech funding and development
James GrahamJames GrahamCEO at Recce Pharmaceuticals

James Graham is the CEO and Managing Director of Recce Pharmaceuticals Ltd., a leading biotech company renowned for its groundbreaking antibiotic solutions.

Under his leadership, Recce Pharmaceuticals has been recognized by the World Health Organization as the most clinically advanced new class of antibiotic in the world.

With a strong background in investment and biotech innovation, James has spearheaded the development of novel treatments targeting pathogens responsible for deadly diseases and sepsis.

Making psychedelic therapy accessible and affordable
Making psychedelic therapy accessible and affordableDr. Prash Puspanathan
Driving innovation in biotech
Driving innovation in biotechDr. Nina Webster
Why AI is the future of clinical trials
Why AI is the future of clinical trialsSaurabh Jain
How to invest with purpose and profit in the biotech industry
How to invest with purpose and profit in the biotech industry Emerald Scofield
Navigating the pathway to success in biotech
Navigating the pathway to success in biotechRebecca McQualter
Navigating the pathway to biotech success
Navigating the pathway to biotech successMegan Baldwin
Show more content
Description

Join us for an insightful conversation with James Graham, CEO of Recce Pharmaceuticals, as he discusses the critical factors driving success in the biotech industry.

In this interview, James shares valuable insights into raising capital, securing non-dilutive funding, and navigating the challenges of developing groundbreaking antibiotic solutions.

Table Of Contents
Strategies for raising capital
Reaching key milestones
Challenges and rewards in biotech
Future plans and vision
0
Your cart